Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

DECHRA PHARMACEUTICALS LIMITED

Company number 03369634

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
13 Dec 2021 RP04SH01 Second filing of a statement of capital following an allotment of shares on 13 September 2021
  • GBP 1,082,226.39
02 Dec 2021 TM01 Termination of appointment of Denise Elaine Goode as a director on 30 November 2021
02 Nov 2021 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES09 ‐ Resolution of authority to purchase a number of shares
  • RES13 ‐ General meetings called 21/10/2021
  • RES10 ‐ Resolution of allotment of securities
28 Oct 2021 AA Group of companies' accounts made up to 30 June 2021
15 Sep 2021 SH01 Statement of capital following an allotment of shares on 13 September 2021
  • GBP 1,082,226.39
  • ANNOTATION Clarification a second filed SH01 was registered on 13/12/2021
01 Jul 2021 SH01 Statement of capital following an allotment of shares on 25 June 2021
  • GBP 1,082,153.23
14 May 2021 CS01 Confirmation statement made on 13 May 2021 with no updates
13 May 2021 SH01 Statement of capital following an allotment of shares on 30 April 2021
  • GBP 1,082,048.26
05 May 2021 CH01 Director's details changed for Mr Anthony Gerard Griffin on 28 April 2021
26 Apr 2021 AP01 Appointment of Mrs Denise Elaine Goode as a director on 26 April 2021
08 Apr 2021 SH01 Statement of capital following an allotment of shares on 8 March 2021
  • GBP 1,081,620.39
14 Jan 2021 SH01 Statement of capital following an allotment of shares on 16 December 2020
  • GBP 1,081,416.46
05 Nov 2020 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES09 ‐ Resolution of authority to purchase a number of shares
  • RES13 ‐ Notice re general meetings not agm 27/10/2020
  • RES10 ‐ Resolution of allotment of securities
04 Nov 2020 AA Group of companies' accounts made up to 30 June 2020
06 Jul 2020 SH01 Statement of capital following an allotment of shares on 8 June 2020
  • GBP 1,080,109.6
15 May 2020 CS01 Confirmation statement made on 13 May 2020 with no updates
14 May 2020 SH01 Statement of capital following an allotment of shares on 13 May 2020
  • GBP 1,028,784.6
16 Mar 2020 SH01 Statement of capital following an allotment of shares on 10 March 2020
  • GBP 1,028,733.87
03 Mar 2020 AP01 Appointment of Elizabeth Alison Platt as a director on 1 March 2020
13 Jan 2020 SH01 Statement of capital following an allotment of shares on 16 December 2019
  • GBP 1,028,632.74
30 Oct 2019 RESOLUTIONS Resolutions
  • RES09 ‐ Resolution of authority to purchase a number of shares
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
30 Oct 2019 AP01 Appointment of Mr Paul Nicholas Sandland as a director on 30 October 2019
28 Oct 2019 AA Group of companies' accounts made up to 30 June 2019
09 Jul 2019 SH01 Statement of capital following an allotment of shares on 10 June 2019
  • GBP 1,026,516.02
20 May 2019 CS01 Confirmation statement made on 13 May 2019 with no updates